EQS-News: aap Implantate AG / Key word(s): StudyAntibacterial silver coating technology: acceleration of human clinical trial through successfully implemented clinical trial protocol changes 25.11.2022 / 16:27 CET/CESTThe issuer is solely responsible for the content of this announcement.aap Implantate AG ("aap" or t.
EQS-News: aap Implantate AG / Key word(s): Quarter Results/9 Month figuresQ3/2022: Again significant growth in the US (+45 %) with sales of EUR 1.0 million; total sales and EBITDA impacted by continued volatile market environment 16.11.2022 / 13:25 CET/CESTThe issuer is solely responsible for the content of this ann.
EQS-News: aap Implantate AG / Key word(s): Preliminary Results/Development of SalesQ3/2022: Solid third quarter with slight sales growth in persistently volatile market environment; US business back on track with significant +45 % sales increase 25.10.2022 / 07:45 CET/CESTThe issuer is solely responsible for the con.